Page last updated: 2024-08-24

3-iodobenzylguanidine and Vasculitis

3-iodobenzylguanidine has been researched along with Vasculitis in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Abdelkefi, C; Abida, R; Belhassen, A; Bouslama, K; El Ouni, A; Hamzaoui, S; Larbi, T; Meddeb, Z; Toujani, S1
Hanaoka, M; Koizumi, T; Kubo, K; Urushihata, K; Yoshiike, F1

Other Studies

2 other study(ies) available for 3-iodobenzylguanidine and Vasculitis

ArticleYear
Pheochromocytoma presenting as an authentic small vessel vasculitis and complicated with pulmonary embolism: An original presentation.
    Annales de cardiologie et d'angeiologie, 2021, Volume: 70, Issue:3

    Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Adult; Diagnosis, Differential; Female; Hemorrhage; Humans; Iodine Radioisotopes; Myocarditis; Myositis; Pheochromocytoma; Pulmonary Alveoli; Pulmonary Embolism; Radiopharmaceuticals; Tomography, X-Ray Computed; Vasculitis

2021
Reduced lung uptake of iodine-123 metaiodobenzylguanidine in patients with myeloperoxidase antineutrophil cytoplasmic antibodies-positive vasculitis.
    Respiration; international review of thoracic diseases, 2006, Volume: 73, Issue:2

    Topics: 3-Iodobenzylguanidine; Aged; Aged, 80 and over; Antibodies, Antineutrophil Cytoplasmic; Biomarkers; Endothelium, Vascular; Female; Humans; Kidney Diseases; Lung; Male; Middle Aged; Radionuclide Imaging; Radiopharmaceuticals; Vasculitis

2006